Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805406/0/en/Bionano-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2023-Results.html

SAN DIEGO, Jan. 08, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq:BNGO) today reported certain unaudited preliminary financial and commercial highlights for the fourth quarter and fiscal year ended December 31, 2023. The Company’s full results for the fourth quarter and the fiscal year ended December 31, 2023 are not yet available.

Read more at globenewswire.com

Related news for (BNGO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.